FDA Inspection 895788 — Oregon Compounding Centers, Inc.

Oregon Compounding Centers, Inc. — FEI 3005580627

The FDA completed an inspection of Oregon Compounding Centers, Inc. on August 28, 2014 in Wilsonville, OR. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 10 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 28, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wilsonville, OR (United States)

Citations

IDCFRDescription
115921 CFR 211.28(a)Clothing appropriate for duties performed
143321 CFR 211.42(c)(10)(iii)Air Supply
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
143521 CFR 211.42(c)(10)(v)Cleaning System
145121 CFR 211.113(b)Procedures for sterile drug products
145221 CFR 211.113(b)Validation lacking for sterile drug products
188321 CFR 211.165(a)Testing and release for distribution
192621 CFR 211.166(b)Adequate number of batches on stability
193221 CFR 211.167(a)Sterility/pyrogen-free testing
457621 CFR 211.192No written record of investigation